Provided by Tiger Fintech (Singapore) Pte. Ltd.

bioAffinity Technologies, Inc.

0.2936
-0.0234-7.38%
Post-market: 0.29360.00000.00%19:52 EDT
Volume:604.59K
Turnover:178.46K
Market Cap:8.08M
PE:-0.41
High:0.3161
Open:0.3050
Low:0.2800
Close:0.3170
Loading ...

Case Study: Cypath® Lung Detects Stage 1a Lung Cancer in High-Risk Patient With Inconclusive Imaging and Low-Risk Serum Test Results

THOMSON REUTERS
·
29 Jul

bioAffinity Technologies Inc. Conducted Annual Stockholders Meeting

Reuters
·
26 Jul

bioAffinity Technologies Secures Canadian Patent for Innovative Lung Cancer Diagnostic Test, CyPath® Lung

Reuters
·
22 Jul

bioAffinity Technologies Receives Notification of Patent Allowance in China for Noninvasive Lung Cancer Diagnostic

Reuters
·
15 Jul

Top Research Reports for Meta Platforms, ServiceNow & Booking

Zacks
·
01 Jul

bioAffinity Technologies Announces Patent Filing for Broad-Spectrum Cancer Therapy Using siRNA Technology

Reuters
·
26 Jun

bioAffinity Technologies Secures Chinese Patent for Innovative siRNA-Based Cancer Therapy

Reuters
·
24 Jun

bioAffinity Technologies CEO Maria Zannes Joins American Lung Association in Texas Leadership Board

Reuters
·
11 Jun

bioAffinity Technologies Inc. Receives Nasdaq Notice for Failing to Meet Listing Requirements

Reuters
·
31 May

Maxim Group Remains a Hold on bioAffinity Technologies, Inc. (BIAF)

TIPRANKS
·
29 May

bioAffinity Technologies Secures U.S. Patent for Innovative Cancer Therapeutic Targeting CD320 and LRP2 Receptors

Reuters
·
28 May

bioAffinity Technologies Inc. Announces "At-The-Market" Stock Offering with WallachBeth Capital LLC

Reuters
·
27 May

BioAffinity Technologies appoints Dr. Gordon Downie as Chief Medical Officer

TIPRANKS
·
20 May

bioAffinity Technologies Appoints Dr. Gordon Downie as Chief Medical Officer to Enhance Early Cancer Detection Efforts

Reuters
·
20 May

bioAffinity Technologies Q1 EPS $(0.16), Inline, Sales $1.85M Miss $2.11M Estimate

Benzinga
·
15 May

Press Release: bioAffinity Technologies Reports First Quarter 2025 Results

Dow Jones
·
15 May

bioAffinity Technologies Inc expected to post a loss of 16 cents a share - Earnings Preview

Reuters
·
10 May

BioAffinity Technologies Closes $3.25 Million Offering

MT Newswires Live
·
08 May

BioAffinity Technologies announces closing of $3.25M offering

TIPRANKS
·
08 May

Crude Oil Rises Sharply; US Trade Deficit Widens In March

Benzinga
·
07 May